
This study aimed to assess the diagnostic efficacy of multiparametric magnetic resonance imaging (mpMRI), 68Ga-PSMA PET/CT, and their combination in detecting, localizing, and staging prostate cancer. The study showed no significant differences in lesion detection or localization among mpMRI, 68Ga-PSMA PET/CT, and combined imaging. However, 68Ga-PSMA PET/CT underestimated local tumor staging, while mpMRI and combined imaging accurately assessed local staging. Lymph node staging showed no significant differences among the three examinations. The combined use of mpMRI and 68Ga-PSMA PET/CT did not provide additional advantages over mpMRI alone.
Like
Save
Share